QQ客服 官方微博 反馈留言

浏览/检索结果: 共11条，第1-10条 帮助 限定条件 发表日期：2021     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China 期刊论文 THORACIC CANCER, 2021 作者:  Shi, Yuequan;  Fang, Jian;  Zhou, Chengzhi;  Liu, Anwen;  Wang, Yan 收藏  |  浏览/下载：65/0  |  提交时间：2022/01/25 advanced lung cancer  immune checkpoint inhibitors  immune-related adverse events  real-world data   A nomogram model based on peripheral blood lymphocyte subsets to assess the prognosis of non-small cell lung cancer patients treated with immune checkpoint inhibitors 期刊论文 TRANSLATIONAL LUNG CANCER RESEARCH, 2021 作者:  Xu, Xiaoling;  Wang, Ding;  Chen, Wei;  Li, Na;  Suwinski, Rafal 收藏  |  浏览/下载：44/0  |  提交时间：2022/02/14 Immune checkpoint inhibitor (ICI)  non-small cell lung cancer (NSCLC)  peripheral blood lymphocyte subsets   The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study 期刊论文 CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021 作者:  Wang, Wenxian;  Gu, Xiaodong;  Wang, Liping;  Pu, Xingxiang;  Feng, Huijing 收藏  |  浏览/下载：30/0  |  提交时间：2022/01/10 Non-small cell lung cancer  PD-L1  Immune checkpoint inhibitor  Immune-related adverse event   Discovery and Development of a Potent, Selective, and Orally Bioavailable CHK1 Inhibitor Candidate: 5-((4-((3-Amino-3-methylbutyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)picolinonitrile 期刊论文 JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 64, 期号: 20, 页码: 15069-15090 作者:  Jin, Tingting;  Xu, Lei;  Wang, Peipei;  Hu, Xiaobei;  Zhang, Runyuan 收藏  |  浏览/下载：23/0  |  提交时间：2022/01/04 The ups, downs and new trends of IDO1 inhibitors 期刊论文 BIOORGANIC CHEMISTRY, 2021, 卷号: 110, 页码: 12 作者:  Chen, Shulun;  Tan, Jing;  Zhang, Ao 收藏  |  浏览/下载：14/0  |  提交时间：2021/08/17 Immunotherapy  Cancer  Indoleamine 2,3-dioxygenase  Tryptophan 2,3-dioxygenase  Inhibitors  Checkpoint Inhibitor   Discovery of a new inhibitor targeting PD-L1 for cancer immunotherapy 期刊论文 NEOPLASIA, 2021, 卷号: 23, 期号: 3, 页码: 281-293 作者:  Wang, Fengling;  Ye, Wenling;  Wang, Shuang;  He, Yongxing;  Zhong, Haiyang 收藏  |  浏览/下载：33/0  |  提交时间：2021/12/10 PD-1  PD-L1  Inhibitor  APBC  Cancer immunotherapy   Design, Synthesis, and Biological Evaluation of Orally Bioavailable CHK1 Inhibitors Active against Acute Myeloid Leukemia 期刊论文 CHEMMEDCHEM, 2021, 页码: 12 作者:  Jin, Tingting;  Wang, Peipei;  Long, Xiubing;  Jiang, Kailong;  Song, Pinrao 收藏  |  浏览/下载：133/0  |  提交时间：2021/05/24 CHK1 inhibitor  diaminopyrimidine  DNA damage response  oral bioavailability   Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2-Breast Cancer Patient With High Tumor Mutational Burden 期刊论文 FRONTIERS IN ONCOLOGY, 2021, 卷号: 10 作者:  Wang, Rong;  Yang, Yuchen;  Ye, Wei-Wu;  Xiang, Jianxing;  Chen, Songan 收藏  |  浏览/下载：44/0  |  提交时间：2021/04/26 breast cancer  immunotherapy  biomarker  TMB  NGS  molecular monitoring   Original Anti-PD1 checkpoint inhibitor with or without chemotherapy for patients with recurrent and metastatic nasopharyngeal carcinoma 期刊论文 TRANSLATIONAL ONCOLOGY, 2021, 卷号: 14 作者:  Jin, Ting;  Zhang, Qun;  Jin, Qi-Feng;  Hua, Yong-Hong;  Chen, Xiao-Zhong 收藏  |  浏览/下载：18/0  |  提交时间：2022/01/25 Nasopharyngeal carcinoma  Metastasis  Chemotherapy  Recurrence  Anti-PD1 checkpoint inhibitor   Fractionated regimen-suitable immunoradiotherapy sensitizer based on ultrasmall Fe4Se2W18 nanoclusters enable tumor-specific radiosensitization augment and antitumor immunity boost 期刊论文 NANO TODAY, 2021, 卷号: 36, 页码: 13 作者:  Zhou, Ruyi;  Yan, Liang;  Dong, Xinghua;  Zhu, Shuang;  Chen, Kui 收藏  |  浏览/下载：20/0  |  提交时间：2021/08/31 Immunoradiotherapy  Abscopal effect  Fractionated regimen  Sandwich-type polyoxotungstate  Fenton reaction  Oxidative stress